Lundbeck Pays Otsuka $200M Upfront in CNS Drug Pact - Nov. 11, 2011

Having trouble viewing this email? View in Browser.

Friday, November 11, 2011  |   |   |   |  Scottish Development International: The home of whisky and the bionic hand, we're the toast of the scientific community. Independent analysis shows that Scotland is a high quality, cost effective location to establish your business project. Enter your details to access our FREE Financial Times benchmarking reports on a range of industries that demonstrate Scotland's competitiveness.   •  Lundbeck Inc. Pays Otsuka Pharmaceutical Co., Ltd. $200 Million Upfront in CNS Drug Pact More... •  ArQule, Inc. (ARQL) License Deal with Daiichi Sankyo, Inc. (D4S.F) Could Land $265 Million More... •  FDA Approves New York Blood Center's HEMACORD(TM) for Stem Cell Transplantation More... •  IntelGenx Corp. Announces FDA Approval of Its High Dose Anti-Depressant CPI-300 More... •  Heart-Attack Stopping Gene Lures Amgen (AMGN), Sanofi (France) (SASY.PA) in Drug Race More... •  FDA, European Medicines Evaluation Agency Agree to Review Astellas Pharma Inc. (YPH.BE) Bladder Drug More... •  Clinical Hold Removed for Helix Biopharma (CC:HBP)'s Topical Interferon Alpha-2b Phase II/III Efficacy Trial IND Application More... •  Johnson & Johnson (JNJ) Funds New R&D Program to Solve the Mysteries of the Brain More... More Top News Download PPD's new whitepaper, Managing Clinical Trials and Central Laboratory Services in China. China is expected to become the second largest pharmaceutical market by 2015. Yet only 152 international, multicenter clinical trials were initiated in China in 2010 despite creation of a centralized State Food and Drug Administration (SFDA), improvements in pharmaceutical industry regulations and growing clinical trial infrastructure. In our new white paper, we detail the recent advancements and remaining challenges in China's regulatory environment and expanding clinical trial infrastructure. We also provide insight into the benefits of leveraging global contract research organizations and the efficiencies gained by integrating central laboratory services along with clinical trial management. Click here to view the whitepaper. •  Copenhagen University Researchers Find Mixed Benefit From Low-Sodium Diets More... •  Create New Life Forms With "Rewritable" Cells, University of Nottingham Study More... •  Big Belly Before Pregnancy May Mean Extra-Big Baby, Cambridge University Study More... •  Knocking Out Key Protein in Mice Boosts Insulin Sensitivity, University of California, San Diego (UCSD) Study More... •  Skin Transformed for Cancer Fight, Oxford University Study More... •  Parkinsonian Worms May Hold the Key to Identifying Drugs for Parkinson's Disease, University of Texas Study More... •  Heavy Meth Use Linked to Schizophrenia, Centre for Addiction and Mental Health Study More... •  High Fiber Cereal Reduce Bowel Cancer Risk, Imperial College London Study More...   More Featured News CHI's 11 Annual PepTalk: The Protein Science Week January 9-13, 2012 | Hotel Del Coronado | San Diego, CA www.chi-peptalk.com Register by Friday, November 11 and Save up to $200! PepTalk 2012 continues the tradition of strong scientific programming centered around protein-based therapeutics. The four distinct protein pipelines focused on formulation, purification, biotherapeutics and expression range from applying protein discovery research, to developing downstream protein products that ultimately lead to clinical applications. Create your own agenda by moving between the tracks and choosing the sessions that best fit your research and networking needs. Please click here for more information. Next-Generation Protein and Peptide Therapeutics • Understand the limitations of monoclonal antibodies, how these relate to molecular structure, and which protein alternatives may offer solutions. • Discover the most innovative delivery technologies that may broaden the applicability of protein therapeutics. • Gain insight into the crucial issue of immunogenicity; understand the regulatory expectations for testing, and the potential options for minimizing. • Compare the pros and cons of the next-generation protein therapeutics, and assess which are making progress through the clinic. Click Here for More Information. Bioscience Technology This magazine provides information to life science/biotech researchers searching for technology, tools and techniques to conduct better, more cost-efficient and effective research. Request Now! • Biotech Beach (Marina del Rey, California) C3 Jian, Inc. Vice President, Product Development Will report directly to the President and CEO of C3 Jian, Inc. (or the Company). In this newly created position, the incumbent will be responsible for the organizations technical product development, while assisting other professionals in clinical, regulatory and manufacturing needs as a member of the Companys senior management team. The position is based in Marina del Rey, California. • BioCapital (Gaithersburg, Maryland) Medical Science & Computing, Inc. T-Cell Assay Supervisor Responsible for the supervision and oversight for all T-cell based methodologies used in clinical vaccine trial testing. Such assays currently include Interferon-gamma Enzyme Linked Immunospot Assays (ELISpot) and Flow Cytometry based Intracellular Cytokine Staining Assays (ICS). The T-Cell Assay supervisor will report directly to the Testing Laboratory Manager and will be responsible for the establishment of ELISpot/ICS Assay standard practices and supervision of analysts performing those methods. • Biotech Bay (South San Francisco, California) Veracyte, Inc. Senior Software Developer Our IT team seeks an individual with the ability to rapidly deliver complete software applications, and write/integrate software programs for commercial, CLIA lab and clinical database systems. The ability to thrive in a challenging, highly diverse team environment is critical. • BioChina (Shanghai, China) Henlius Biopharmaceuticals, Inc. Director/Senior Director Bio-Process Development Seeking an experienced bio-process scientist or engineer to manage and lead our upstream process development group in Shanghai, China. This position is responsible for development, scale-up, transfer, and characterization of cell culture processes for therapeutic protein production. • Pharm Country (Branchburg, New Jersey) ImClone Systems Corporation Senior Specialist-QA Product Complaints Responsible for the activities associated with the evaluation of clinical product complaints from a quality and technical perspective. The incumbent will lead and provide support for interactions with Lilly complaint groups and internal functional areas to ensure that product complaint investigations are thorough and closed in a timely manner. Get Noticed! Add your resume to the BioSpace Career Center! See more than 5,000 job postings in the BioSpace Career Center! BioSpace Life Science Career Fairs are the biotech industry's premier career events. Featuring well-respected employers from around the nation, our job fairs attract top candidates in the biotech, pharmaceutical, life science and medical device industries. With such a great number of recruiters and hiring managers from top biotech companies attending our career fairs, there are an abundance of opportunities available for job seekers. Many different disciplines within the industry are represented bringing a diversity of candidates to our job fairs. Companies seeking pharmaceutical sales representatives and marketing jobs regularly attend our job fairs. Engineering and technical jobs can be found, as well as regulatory jobs and positions in QA/QC. Individuals desiring a science job or a research job will find many opportunities at our job fairs. In addition, hiring managers seeking candidates for clinical research jobs also attend our events. More information about BioSpace's Career Fairs BioSpace White Paper Biotech Career Fairs For Job Seekers 101: Control Your Experience By June Salvati, BioSpace Director of Events and Corporate Services Avrio Biopharmaceuticals 4 Chrysler Irvine, California 92618 U.S.A. Phone: 866-982-8746 Fax: 949-462-0821 Avrio Biopharma, a wholly-owned subsidiary of Irvine Pharmaceutical Services, is a premier contract development and manufacturing organization providing support to the pharmaceutical, biopharmaceutical, and medical device industries. More Company Profiles FREE Subscription to Pharmaceutical Processing Pharmaceutical Processing magazine is the must-read information source for news of products, technologies and applications for pharmaceutical and biopharmaceutical manufacturing professionals. Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship BioSpace Inc. 6465 South Greenwood Plaza, Suite 400 Centennial, Colorado 80111 U.S.A. Phone: 877-277-7585 Fax: 800-595-2929 BioSpace Inc. 90 New Montgomery Street, Suite 414 San Francisco, California 94105 U.S.A. Phone: 877-277-7585 Fax: 415-576-9217 Send questions and comments to the BioSpace News Beat Team. Editor & Publisher: Rosemary Do Editorial & Production Staff: Lana Ho, Maysa Darwish, Tammy Liu, Michelle Wong BioSpace.com - Life. Science. Community. • BioSpace is a registered trademark of BioSpace, Inc. • Please distribute this e-cast freely. • Credit any excerpts as follows: Copyright 2011 BioSpace http://www.biospace.com • While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes. If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here. Safely unsubscribe from Biospace.com e-mail at any time by managing your account here.